ARDSLEY ADVISORY PARTNERS LP - Q3 2019 holdings

$446 Million is the total value of ARDSLEY ADVISORY PARTNERS LP's 133 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .

 Value Shares↓ Weighting
NRG  NRG ENERGY INCput$4,950,000
+12.8%
125,0000.0%1.11%
+60.2%
IDSY  I D SYSTEMS INC$2,798,000
-7.0%
511,5230.0%0.63%
+32.0%
GWRS  GLOBAL WTR RES INC$1,385,000
+13.4%
117,0000.0%0.31%
+61.1%
CRUS  CIRRUS LOGIC INCput$1,340,000
+22.6%
25,0000.0%0.30%
+74.4%
FB  FACEBOOK INCput$890,000
-7.8%
5,0000.0%0.20%
+31.6%
MDT  MEDTRONIC PLC$869,000
+11.6%
8,0000.0%0.20%
+58.5%
VRTX  VERTEX PHARMACEUTICALS INC$847,000
-7.6%
5,0000.0%0.19%
+31.0%
VTNR  VERTEX ENERGY INC$571,000
-24.5%
504,3060.0%0.13%
+7.6%
CERS  CERUS CORP$412,000
-8.2%
80,0000.0%0.09%
+29.6%
QTNT  QUOTIENT LTD$389,000
-16.9%
50,0000.0%0.09%
+17.6%
TNDM  TANDEM DIABETES CARE INC$354,000
-8.5%
6,0000.0%0.08%
+29.5%
ALDX  ALDEYRA THERAPEUTICS INC$248,000
-12.1%
47,1000.0%0.06%
+27.3%
HCHC  HC2 HLDGS INC$118,000
-0.8%
50,0000.0%0.03%
+36.8%
CBAY  CYMABAY THERAPEUTICS INC$102,000
-28.7%
20,0000.0%0.02%0.0%
NEPT  NEPTUNE WELLNESS SOLUTIONS I$89,000
-18.3%
25,0000.0%0.02%
+17.6%
PTE  POLARITYTE INCcall$81,000
-43.4%
25,0000.0%0.02%
-21.7%
CPST  CAPSTONE TURBINE CORP$77,000
-34.7%
150,0000.0%0.02%
-10.5%
SEEL  SEELOS THERAPEUTICS INC$46,000
-58.2%
50,0000.0%0.01%
-41.2%
NVTRQ  NUVECTRA CORP$34,000
-59.5%
25,0950.0%0.01%
-38.5%
CORV  CORREVIO PHARMA CORP$25,000
-7.4%
12,5000.0%0.01%
+50.0%
ATNM  ACTINIUM PHARMACEUTICALS INC$17,000
-10.5%
75,0000.0%0.00%
+33.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUNOPTA INC42Q3 202312.1%
MICROSOFT CORP33Q3 20235.7%
MARRONE BIO INNOVATIONS INC29Q2 20223.9%
SERVICENOW INC28Q3 20231.9%
FORTRESS TRANS INFRST INVS L27Q3 20227.6%
PROSHARES TR26Q3 20236.6%
FERROGLOBE PLC26Q3 20232.4%
HANNON ARMSTRONG SUST INFR C25Q3 20205.2%
SUNRUN INC25Q3 20236.3%
JAZZ PHARMACEUTICALS PLC24Q2 20208.0%

View ARDSLEY ADVISORY PARTNERS LP's complete holdings history.

Latest significant ownerships (13-D/G)
ARDSLEY ADVISORY PARTNERS LP Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bioceres Crop Solutions Corp.January 25, 20231,854,0003.0%
CANTALOUPE, INC.January 25, 20233,150,0004.4%
Stronghold Digital Mining, Inc.Sold outJanuary 25, 202300.0%
MARRONE BIO INNOVATIONS INCFebruary 08, 202218,335,76710.4%
Just Energy Group Inc.February 12, 2021450,0000.9%
SunOpta Inc.February 12, 20213,396,5143.8%
USA TECHNOLOGIES INCFebruary 12, 20213,725,5755.7%
AMERICAN SUPERCONDUCTOR CORP /DE/January 26, 2018314,3771.5%
BioScrip, Inc.January 26, 201890,0000.1%
APPLIED OPTOELECTRONICS, INC.Sold outFebruary 14, 201700.0%

View ARDSLEY ADVISORY PARTNERS LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G/A2023-01-25
SC 13G/A2023-01-25
SC 13G2023-01-25
13F-HR2022-11-14
13F-HR2022-08-15

View ARDSLEY ADVISORY PARTNERS LP's complete filings history.

Compare quarters

Export ARDSLEY ADVISORY PARTNERS LP's holdings